
Matthew A Manning MD FASTRO
Central Nervous System Cancer, Thoracic Cancer, Urologic Cancer
Radiation Oncologist, Clinical Informaticist
Join to view full profile
2400 West Friendly AvenueGreensboro, NC 27403
Phone+1 336-832-1100
Dr. Manning is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Matthew Manning, MD, is a radiation oncologist based in Greensboro, NC, with subspecialties in central nervous system, thoracic, and urologic cancers. He completed his education, internship, and residency at Virginia Commonwealth University and is currently a physician and clinical assistant professor. Manning has significant experience with breast, lung, and prostate cancers, stereotactic radiosurgery, and sarcomas. In addition to his clinical work, Manning is a published author with papers in renowned journals like Neuro-Oncology and Journal of Clinical Oncology. He has participated in clinical trials and has received several awards for his work, including CMS Meaningful Use Stage 1 Certification and the President’s Award from The American Brachytherapy Society.
Education & Training
Virginia Commonwealth University Health SystemResidency, Radiation Oncology, 1997 - 2001
Virginia Commonwealth University Health SystemInternship, Internal Medicine, 1996 - 1997
Virginia Commonwealth University School of MedicineClass of 1996
The College of William and MaryB.S., Chemistry, 1992
Certifications & Licensure
NC State Medical License 2001 - 2027
VA State Medical License 1998 - 2010
American Board of Preventive Medicine Clinical Informatics
American Board of Radiology Radiation Oncology- Racial Equity InstituteAnti-Racism Workshop
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2014-2017
Clinical Trials
- Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2012 Dec 20
Publications & Presentations
PubMed
- 43 citationsEffect of an Antiracism Intervention on Racial Disparities in Time to Lung Cancer Surgery.Marjory Charlot, Jacob Newton Stein, Emily Damone, Isabella Wood, Moriah Forster
Journal of Clinical Oncology. 2022-06-01 - 67 citationsPreoperative Radiosurgery for Resected Brain Metastases: The PROPS-BM Multicenter Cohort Study.Roshan S Prabhu, Reshika Dhakal, Zachary K Vaslow, Tu Dan, Mark V Mishra
International Journal of Radiation Oncology, Biology, Physics. 2021-11-01 - 18 citationsLeptomeningeal disease and neurologic death after surgical resection and radiosurgery for brain metastases: A multi-institutional analysis.Roshan S. Prabhu, Brandon E. Turner, Anthony L. Asher, S. Marcrom, John B. Fiveash
Advances in Radiation Oncology. 2021-01-08
Journal Articles
- Bladder preservation for localized muscle-invasive bladder cancer: the survival impact of local utilization rates of definitive radiotherapyKozak, K.R., Hamidi, M., Moody, J.S., International Journal Radiation Oncology Biology and Physics, 1/1/2012
- The effect of high-dose-rate brachytherapy dwell sequence on cell survivalArnfield, R., Lin, P., Arthur, D., Kavanagh, B., Zwicker, R., Schmidt-Ullrich, R., International Journal Radiation Oncology Biology and Physics, 1/1/2002
- Accelerated superfractionated radiotherapy with concomitant boost for head and neck carcinomasMorris, M., Schmidt-Ullrich, R., DiNardo, L., Silverman, L., Clay, L., Johnson, C., Amir, C., International Journal Radiation Oncology Biology and Physics, 1/1/2002
Abstracts/Posters
- SU-E-T-197: Comparing Quality Assurance Strategies for Single Isocenter Treatments of Multiple Brain MetastasesMaurer J, Liu H, Wiant D, Koch K, Sintay B, Med Phys, 1/1/2015
- SU-E-T-177: Clinical Experience with Spirometer Guided Breath Hold Lung SBRTLiu H, Sintay B, Maurer J, Hayes L, Wiant D, Med Phys, 1/1/2015
- SU-E-J-187: Management of Optic Organ Motion in Fractionated Stereotactic Radiotherapywith Maurer J, Med Phys, 1/1/2015
Authored Content
- How ASTRO Is Tracking Its Members' Well-Being During COVID-19November 2020
Press Mentions
Hype or Hope? 14 Oncology Leaders Weigh in on GLP-1sMarch 2nd, 2026
ASTRO: Patient Navigation Key to Mitigating RT Treatment DisparitiesSeptember 29th, 2025
Fuse Oncology, ACRO Partner to Integrate Clinical Pathways PlatformMarch 13th, 2025
Committees
- Oncology Section Rep, Cone Health Medical Executive Committee (MEC) 2017 - 2020
Professional Memberships
- Member
- American Brachytherapy Society (ABS)Member
External Links
- LinkedIn Profilehttps://www.linkedin.com/in/radiationoncology/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: